Issued Patents

Issued Patents: Technologies Available for Licensing

For non-confidential information about technologies from Children’s National Hospital that are available for licensing, please visit the links below.

Antibody-based Method for Isolating TH1 and TH2 Helper Lymphocytes from Human Peripheral Blood (Patent 7,919,265)
Biochemical Marker For Diagnosing a Leukodystrophy (Patent 7,691,640)
Device and Method for Classifying a Condition Based on Image Analysis (Patent 9,443,132)
Enhanced Control of Flexible Endoscopes through Human-Machine Interface (Patent 9,173,551)
Generation of Broadly-Specific, Virus-Immune Cells Targeting Multiple HIV Antigens for Preventive and Therapeutic Use (Patent 9,885,021)
ID-Protein Targeted Tumor Cell Vaccine (Patent 9,795,660)
Management, Assessment and Treatment Planning for Inflammatory Bowel Disease (Patent 9,883,817)
Method of Reducing the Activation of TH2 Lymphocytes (Patent 8,057,795)
Methods and Compositions for Treating HIV Infection (Patent 8,211,866)
Methods and Compositions for Treating HIV Infection (Patent 8,497,251)
Methods and Compositions for Treating HIV Infection (Patent 9,006,202)
Patient Mounted MRI and CT Compatible Robot for Needle Guidance in Interventional Procedures (Patent 9,326,825)
Prussian Blue-Inspired Constructs for Multimodal Imaging and Therapy (Patent 9,561,183)
Screening Test for the Lethal Genetic Trait of Recurrent Spontaneous Pregnancy Loss (Patent 6,268,145)